SCHEMBL4099243

SCHEMBL4099243

COc1ccc2c(c1)c(C(=O)C(=O)Nc1ncc(C)s1)c(C)n2Cc1ccc(Cl)cc1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.51
FAAH O00519 1/20 0.47
PLA2G2A P14555 6/20 0.46
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
LMNA P02545 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MAPT P10636 2/20 0.41
NFKB1 P19838 2/20 0.41
RGS12 O14924 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
PKM P14618 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
CYP2C19 P33261 1/20 0.41
GNAI1 P63096 1/20 0.41
PMP22 Q01453 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2995765 0.87 PLA2G2A (0.46) FAAHPLA2G2AMEN1KMT2ALMNA
SCHEMBL2160358 0.83 FAAH (0.56) FAAHPLA2G2AMEN1KMT2ALMNA
SCHEMBL2169580 0.83 PLA2G2A (0.50) FAAHPLA2G2AMEN1KMT2ALMNA
SCHEMBL2168611 0.83 PLA2G2A (0.56) FAAHPLA2G2AMEN1KMT2ALMNA
SCHEMBL2168985 0.83 FAAH (0.60) FAAHPLA2G2AMEN1KMT2ALMNA
SCHEMBL2159594 0.82 FAAH (0.53) PTGS2FAAHPLA2G2AMEN1KMT2A
SCHEMBL2170586 0.82 FAAH (0.53) FAAHPLA2G2AMEN1KMT2ALMNA
SCHEMBL2171336 0.82 FAAH (0.49) PTGS2FAAHPLA2G2AMEN1KMT2A
SCHEMBL2160399 0.82 FAAH (0.71) FAAHPLA2G2AMEN1KMT2ALMNA
SCHEMBL2169000 0.82 FAAH (0.51) PTGS2FAAHPLA2G2AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090118503-A1 FAAH INHIBITORS IRONWOOD PHARMACEUTICALS, INC. 2009-05-07 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118503-A1 FAAH INHIBITORS FAAH, FAAH2, CNR2 PTGS2 29/4885FAAH 1/4885PLA2G2A 242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.